Virtual booth

Scroll below to find out more about the Biofabrication 2022 sponsors!

Platinum sponsors

Rousselot is the global leader in collagen-based solutions for the food, health & nutrition, biomedical, and pharmaceutical sectors. Based on over 130 years of expertise on gelatin and collagen, Rousselot Biomedical supplies high quality pharmaceutical grade biomaterial for tissue engineering, regenerative medicine, drug delivery systems, cell therapies, surgical and parenteral applications, wound healing and organ on a chip.

Rousselot biomedical business develops purified, modified and non-modified, low endotoxin gelatins and collagens, customized and scaled to a wide range of specifications, for fast, reliable product development.

Find out more at

BIO3DPRINTING is dedicated to the design and manufacturing of 3D multiscale and multimaterial bioprinting technologies for enabling advanced tools for the medical, biotechnology and life science industry.
The patented Electrospider is a fully customizable 3D multiscale and multiscale robotic platform providing different biofabrication technologies within a single bioprinter. By combining pressure-driven extrusion, electrospinning/electrowriting, and pneumatic drop dispensing in the same robotic platform it allows to process simultaneously several biomaterials with millimetric and/or nanometric resolution to produce a wide range of complex structures for 3D cell cultures.
Biomaterials compatible with Electrospider range from hydrogels, cell-laden hydrogels, culture media, particle suspensions to thermoplastic polymers, pastes, particle suspension and silicones. Electrospider is also designed to be integrated with a wide range of bioprinting add-on modules to meet specific customer needs. Electrospider rigorously complies with all relevant CE safety requirements.

Gold sponsors

CELLINK offers premium bioinks, bioprinters and services that enable critical breakthroughs in 3D cell culturing, tissue engineering and drug development.

By releasing the first universal bioink in 2016, CELLINK democratized the cost of entry for researchers around the world and played a major role in turning the then up-and-coming field of 3D bioprinting into the thriving $1 billion industry it is today. CELLINK best-in-class bioinks, bioprinters, software and services are being used by the foremost academics and R&D labs and have enabled critical breakthroughs in a wide range of applications from 3D cell culturing to tissue engineering to drug development.

CELLINK is dedicated to taking the on-demand biofabrication of human organs and tissues to the next level, in line with BICO’s vision to leverage bioconvergence in the life sciences and create the future of health.

Find out more at

With over 70 highly qualified employees, Nanoscribe develops products and services on the basis of Nanoscribe’s Two-Photon Polymerization technology. Providing hardware, software, materials and processes as a complete solution is the key to the customers’ success today. More than 2,000 active users of Nanoscribe systems located in over 30 countries rely on the technology and systems.

Over 25% of the annual revenues are regularly invested in the future of microfabrication. Thus Nanoscribe delivers smart solutions that inspire our customers and enable them to materialize ground-breaking ideas.

As the pioneer and market leader in high-precision additive manufacturing, Nanoscribe pushes the limits of 3D printing and challenge the state-of-the-art in microfabrication. Its technology empowers cutting edge science and drives industrial innovations in a wide variety of sectors such as microoptics, micromechanics, biomedical engineering, and photonics technologies.

Find out more at

At MP we are convinced that the characterization of materials and the intelligent choice of innovative solutions can translate into competitive advantages and economic savings. It is in this context and with this objective that our company, the products we offer and the professionalism of our employees become real strategic partners guiding and following customers in optimizing investments and achieving results.

The customer is our most important resource and our primary mission is to, through quality, innovation and timeliness, meet their needs by ensuring a highly versatile and excellent service.

Find out more at

MERCK empowers the scientific community. Its tools, services, and digital platform make research simpler, more exact, and help to deliver breakthroughs more quickly. MERCK provides progressive treatment solutions that help improve access to health thanks to the accuracy of our tests and the reliability of our medicine. As a company, we are at the forefront of digital living. Our science sits inside technologies that change the way we access, store, process, and display information. Our innovative technology drives human progress and opens new possibilities to transform life on Earth as we know it.
Thanks to the constant curiosity of our employees, we are making discoveries that can change the landscape of entire industries. For more than 350 years, we’ve been pushing the boundaries of what’s possible, and we’ll continue to do so in the years to come.

Find out more at

Silver sponsors

CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing.

CollPlant revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes the rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, CollPlant is developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics.

Find out more at

ViscoTec manufactures dispensing & filling systems and dosing components for semi-automatic and fully-automatic production plants and assembly processes. The precise, reliable, fast and sophisticated technology convinces in the most diverse applications – and this worldwide.

ViscoTec high-quality products are used in a wide variety of industries such as e-mobility, aerospace, electronics, food, biochemistry, pharmaceuticals, cosmetics and medical technology. As a customer, you always have the advantage of using a technology that not only offers technical features but above all one thing: Reliable, exact, fast dosing, with which you increase the quality of your products.

Find out more at

Content of the SFB/TRR 225 is the exploration of the fundamentals of biofabrication and its systematic exploitation with the aim and vision to generate functional human tissue models (12-year perspective).

The first funding period (1st FP) of the TRR225 was mainly focused on the development of materials and processes that enable high cell survival in the printing process. With the growing number of options to print living cells, the post-fabrication behavior of the cells in the printed constructs has become an increasing focus. To date, however, causal relationships between fabrication conditions and cell behavior beyond survival, such as proliferation, remain largely unclear. Therefore, in the 2nd FP, the TRR225 will focus on intensifying the interlinking of material and method development with the construction of tissue models, which was developed in the 1st FP. Thereby, the central questions move from the printability optimization of the bio-inks (1st FP) to the post-fabrication behavior of the cells in the bio-fabricates, the assurance of long-term cell survival (supply) as well as the construction of tissue models and material and process design focused on the respective application. The TRR225 sites had already laid a unique foundation by establishing the first two biofabrication courses and the first two professorships in biofabrication. During the 1st FP, further structure-building measures were taken, such as the creation of four new professorships and a junior research group, as well as the foundation of the interfaculty Institute for Functional Materials and Biofabrication (IFB) and the initiation of the research building Center of Polymers for Life (CPL). Together, the three sites have received Bavarian start-up funding for the formation of an excellence network (title: Cellular Hybrids), for which TRR225 is a supporting pillar. The success of the TRR225 in the 1st FP is thus also visible through these developments.

Find out more at

Medicine is evolving and those at the frontline who are pushing boundaries, making remarkable discoveries and changing lives, need the right tools and support to take them into the future.

As a Swiss Med Tech company, REGENHU’s mission is to enable our users to reach the next level in their work, goals and ambitions. This is why REGENHU is focusing on creating bioprinting instruments to help them do just that.

REGENHU customer-focused approach, visionary outlook, advanced instruments and user-friendly software that helps them perform tasks with accuracy and repeatability, are at the heart of everything we do.

We are an ambitious, passionate and driven team that is building research instruments for our customers today, with a view of creating tools that will provide their manufacturing needs of the future. We are already engaged in building these future generation bioprinting instruments alongside our new SHAPER software, which is specifically configured for biofabrication and for manufacturing the future of medicine. Together with our users, we are shaping the future of medicine today.

Find out more at

POLBIONICA mission is to bring 3D printing of the bionic pancreas into clinical practice and improve the quality of life for diabetic patients worldwide.

POLBIONICA is a company established by the Foundation on Research and Development of Science to commercialise 3D bionic pancreas research. The bionic pancreas is an organ that will restore the body’s ability to regulate blood sugar levels. Using novel 3D bioprinting technologies, we created a fully functional organ from living cells. Its creation raises hopes for success in the fight against Type I diabetes. 

Find out more at

The technology of Optics11 Life is based on two key elements: fiber optic sensing and state-of-the-art mechatronics. This combination allows the company to develop cutting-edge measurement systems which are highly competitive in the life science field.

Optics11 Life has refined the optical fiber Fabry-Perôt interferometry for force sensing to deliver highly sensitive, affordable and user-friendly devices. As a result, our fiber-optic based force sensors, are providing a unique solution for micro-mechanical analysis of soft and living materials. To put these sensors to optimal use, Optics11 Life engineers state-of the art mechatronic solutions. This allows our instruments to measure mechanical properties of complex materials with uneven topography in physiological conditions.

Also, Optics11 Life instruments can perform various mechanical measurements, such as static and dynamic indentation, including creep, stress-relaxation and DMA (Dynamic Mechanical Analysis). Furthermore, load-displacement curves are analyzed to provide Young’s, storage and loss moduli.

Find out more at

Bronze sponsors

BIO INX® is a spin-off project of Ghent University focusing on the commercialisation of materials and bio-inks for 3D bioprinting or biofabrication by utilizing decades of academic experience in the field of polymers and biomaterials. By offering a unique material portfolio with a diverse range of material properties, the applications become nearly limitless: the bio-inks can be applied for various tissue types with applications in regenerative medicine and drug and cosmetics screening. Additionally, by offering a bio-ink portfolio suitable for multiple printing technologies, attainable resolutions range from hundreds of micrometers to hundreds of nanometers.

Our multidisciplinary team with backgrounds in chemistry and biomedical engineering has a combined 20 years of expertise in the field of polymers, (bio)materials, 3D printing and tissue engineering. Therefore we can provide you with the best possible solutions for all your biofabrication needs.

Find out more at

Building upon a broad expertise in micromachining technologies, GeSiM has evolved into a bioinstrumentation company focusing on submicroliter liquid handling instruments and microfluidics.

GeSiM is specialized in liquid handling automation, microfluidics and micro contact printing. As a leading supplier of submicroliter dispensers, GeSiM developed a unique design for piezoelectric pipetting tips, based on silicon-glass chips. The benchtop pipetting system Nano-Plotter runs up to 16 of these accurate dispensers and is mainly used as non-contact arrayer for microarrays, biochips and biosensors. The Nano-Plotter line follows a strictly modular concept and “grows” with the applications of their owners. Post sales upgrade and a variety of accessories help to bridge the gap from research to production. The Nano-Plotter is successfully used for the production of (FDA) certified diagnostic products. Liquid handling by contact printing is available with the GeSiM micro-contact printers. These instruments transfer sample into tiny 2-dimensional patterns or generate 3-dimensional structures by Nano-Imprint-Lithography (NIL). A patented stamping technology features PDMS stamps for accurate image transfer. Recent developments are focused on instrumentation for 3D printing of biocompatible materials, e.g. Hydrogels, Alginate, thermoplastic biopolymers. Common 3D printers are usually not capable of processing biocompatible materials. In addition, GeSiM has devoted itself to the development of microfluidic flowthrough systems. Micro structuring methods are used to manufacture miniaturized fluidic components from silicon, glass, ceramics and PDMS to create products which cannot be made by conventional methods.

Find out more at

Readily3D developed Tomolite and Apparite to make research in biosciences quicker and more efficient. Founded in 2020, Readily3D originates from a research work started in 2017 at Ecole Polytechnique Fédérale de Lausanne. Existing bioprinting technologies are slow, which tends to reduce cell viability. They also have a poor ability to produce complex anatomical structures, such as vasculatures. To overcome these limitations, we created Tomolite: a unique bioprinter, allowing biologists to print an entire cell-laden volume at once, in less than a minute and without impairing cell viability.

Currently, Readily3D team collaborates with biologists to explore innovative applications of tomographic 3D printing in biosciences. Since 2019, pilot tests of Tomolite and Apparite have begun in European life sciences laboratories. Readily3D is continuously looking for more users to further explore the potential of its technology.

Find out more at


UpNano is a system provider for high-resolution 3D printing. In addition to the development, production and manufacturing of printing systems and the corresponding operating software, UpNano offers printing materials and accessories optimized for the process. Quality and environmental awareness are two fundamental prerequisites which are reflected in the ISO 9001 and 14001 certifications of the company.

Find out more at

The home of scientific content from IOP Publishing and our partners.